Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8748 | 1152 | 33.4 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
335 | 17284 | BLADDER CANCER//CYSTECTOMY//URINARY DIVERSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NMP22 | Author keyword | 144 | 98% | 3% | 39 |
2 | UROVYSION | Author keyword | 62 | 85% | 3% | 33 |
3 | URINE CYTOLOGY | Author keyword | 44 | 42% | 7% | 79 |
4 | NUCLEAR MATRIX PROTEIN 22 | Author keyword | 27 | 78% | 2% | 18 |
5 | URINARY CYTOLOGY | Author keyword | 21 | 46% | 3% | 33 |
6 | BTA STAT | Author keyword | 20 | 100% | 1% | 9 |
7 | IMMUNOCYT | Author keyword | 20 | 100% | 1% | 9 |
8 | BLADDER TUMOR ANTIGEN | Author keyword | 18 | 89% | 1% | 8 |
9 | MARCADO TUMORALES | Address | 18 | 89% | 1% | 8 |
10 | PROT UNIT RUHR EUROPE PURE | Address | 15 | 82% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NMP22 | 144 | 98% | 3% | 39 | Search NMP22 | Search NMP22 |
2 | UROVYSION | 62 | 85% | 3% | 33 | Search UROVYSION | Search UROVYSION |
3 | URINE CYTOLOGY | 44 | 42% | 7% | 79 | Search URINE+CYTOLOGY | Search URINE+CYTOLOGY |
4 | NUCLEAR MATRIX PROTEIN 22 | 27 | 78% | 2% | 18 | Search NUCLEAR+MATRIX+PROTEIN+22 | Search NUCLEAR+MATRIX+PROTEIN+22 |
5 | URINARY CYTOLOGY | 21 | 46% | 3% | 33 | Search URINARY+CYTOLOGY | Search URINARY+CYTOLOGY |
6 | BTA STAT | 20 | 100% | 1% | 9 | Search BTA+STAT | Search BTA+STAT |
7 | IMMUNOCYT | 20 | 100% | 1% | 9 | Search IMMUNOCYT | Search IMMUNOCYT |
8 | BLADDER TUMOR ANTIGEN | 18 | 89% | 1% | 8 | Search BLADDER+TUMOR+ANTIGEN | Search BLADDER+TUMOR+ANTIGEN |
9 | URINE MARKER | 12 | 75% | 1% | 9 | Search URINE+MARKER | Search URINE+MARKER |
10 | URINE MARKERS | 11 | 60% | 1% | 12 | Search URINE+MARKERS | Search URINE+MARKERS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NMP22 | 168 | 91% | 6% | 70 |
2 | VOIDED URINE | 133 | 63% | 12% | 133 |
3 | BTA STAT TEST | 108 | 86% | 5% | 55 |
4 | NUCLEAR MATRIX PROTEIN 22 | 93 | 86% | 4% | 48 |
5 | BTA STAT | 85 | 92% | 3% | 34 |
6 | VOIDED URINE CYTOLOGY | 80 | 90% | 3% | 35 |
7 | CARE PROTEOMIC ASSAY | 50 | 74% | 3% | 37 |
8 | MULTIPROBE FISH | 47 | 86% | 2% | 24 |
9 | URINARY CYTOLOGY | 41 | 56% | 4% | 50 |
10 | BTA TRAK ASSAY | 37 | 100% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses | 2003 | 166 | 57 | 88% |
Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer | 2011 | 52 | 101 | 73% |
Urine markers for bladder cancer surveillance: A systematic review | 2005 | 225 | 80 | 83% |
Urinary markers in bladder cancer | 2008 | 77 | 56 | 79% |
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer | 2010 | 66 | 178 | 48% |
Tumor markers in the diagnosis of primary bladder cancer. A systematic review | 2003 | 112 | 45 | 76% |
Biornarkers for defection and surveillance of bladder cancer | 2008 | 57 | 68 | 72% |
Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests | 2013 | 16 | 142 | 55% |
Bladder Cancer Biomarkers: Review and Update | 2014 | 9 | 72 | 36% |
DNA methylation-based biomarkers in bladder cancer | 2013 | 17 | 76 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MARCADO TUMORALES | 18 | 89% | 0.7% | 8 |
2 | PROT UNIT RUHR EUROPE PURE | 15 | 82% | 0.8% | 9 |
3 | ONCOL DIAGNOST UNIT | 10 | 34% | 2.2% | 25 |
4 | HLTH PROTECT OCCUPAT SAFETY | 8 | 100% | 0.4% | 5 |
5 | PATHOL SUD | 3 | 57% | 0.3% | 4 |
6 | ABBOTT MOL | 2 | 67% | 0.2% | 2 |
7 | CLEVELAND CLIN UROL | 2 | 50% | 0.3% | 3 |
8 | ANDROL ONCOL | 2 | 40% | 0.3% | 4 |
9 | GERMAN SOCIAL ACCID INSURANCE IPA | 2 | 28% | 0.4% | 5 |
10 | BLADDER CANC GRP | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000258850 | FGFR3//GENES P53//DBCCR1 |
2 | 0.0000212667 | COMPUTER BASED CLASSIFICATION//BLADDER WASHING//TRANSITIONAL CELL BLADDER CANCER |
3 | 0.0000179834 | MICROSCOPIC HEMATURIA//HEMATURIA//HAEMATURIA |
4 | 0.0000150245 | SUPERFICIAL BLADDER CANCER//NON MUSCLE INVASIVE BLADDER CANCER//BACILLUS CALMETTE GUERIN |
5 | 0.0000089069 | CELL BLOCK//CYTORICH RED//CELLIENT |
6 | 0.0000081150 | WHO ABORAT FOOD NUTR POLICIES//STUDIES MED PROGRAMS SERV//COMPLEX GENET |
7 | 0.0000068876 | NEPHROURETERECTOMY//UPPER URINARY TRACT//UPPER TRACT UROTHELIAL CARCINOMA |
8 | 0.0000055634 | URINARY PROTEOMICS//URINARY PROTEOME//URINE PROTEOME |
9 | 0.0000053109 | VIRTUAL CYSTOSCOPY//BLADDER NEOPLASMS STAGING//BLADDER NEOPLASMS CT |
10 | 0.0000052841 | UROPLAKINS//UROPLAKIN//ASYMMETRIC UNIT MEMBRANE |